MedPath
FDA Approval

Diatrizoate Meglumine and Diatrizoate Sodium

December 18, 2023

HUMAN PRESCRIPTION DRUG LABEL

Manufacturing Establishments (1)

Annora Pharma Private Limited

Camber Pharmaceuticals, Inc.

650980746

Products (1)

Diatrizoate Meglumine and Diatrizoate Sodium

31722-019

ANDA215049

ANDA (C73584)

ORAL, RECTAL

December 18, 2023

EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
DIMETHICONEInactive
Code: 92RU3N3Y1OClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
STRAWBERRYInactive
Code: 4J2TY8Y81VClass: IACT
Code: V5403H8VG7Class: ACTIBQuantity: 100 mg in 1 mL
Code: 3X9MR4N98UClass: ACTIBQuantity: 660 mg in 1 mL

Drug Labeling Information

HOW SUPPLIED SECTION

HOW SUPPLIED

Diatrizoate Meglumine and Diatrizoate Sodium Solution USP is available as clear, aqueous, pale yellow color solution, with strawberry flavor in packages of:
Twenty-four 30 mL single dose bottles (NDC 31722-019-30).
Twelve 120 mL single dose bottles (NDC 31722-019-12).
Storage
Protect from light. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]; avoid excessive heat.

Camber_logo

Manufactured for:
Camber Pharmaceuticals, Inc.
Piscataway, NJ 08854

By: Annora Pharma Pvt. Ltd.
Sangareddy - 502313, Telangana, India.

Revised: 11/2023


© Copyright 2025. All Rights Reserved by MedPath